E. Chéreau
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 31
- Endometriosis Research and Treatment 17
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments 16
- Uterine Myomas and Treatments 9
- Surgery top 5%
- Intraperitoneal and Appendiceal Malignancies 21
- Anorectal Disease Treatments and Outcomes 6
-
- Breast Cancer Treatment Studies 8
-
- Pelvic floor disorders treatments 6
- Co-authors
- Émile DaraïRoman RouzierMarcos BallesterFrédèric SelleCharles CoutantÉric LambaudieMarc BazotA. Cortez
- Journals
- International Journal of Gynecological Cancer (7 papers)American Journal of Obstetrics and Gynecology (3 papers)European Journal of Surgical Oncology (3 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
E. Chéreau
73 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 74
- Reproductive Medicine 754
- Obstetrics and Gynecology 520
- Surgery 586
- Cancer Research 151
- Oncology 212
Countries citing papers authored by E. Chéreau
This map shows the geographic impact of E. Chéreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Chéreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Chéreau more than expected).
Fields of papers citing papers by E. Chéreau
This network shows the impact of papers produced by E. Chéreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Chéreau. The network helps show where E. Chéreau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Chéreau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 5 | |
| 2 | 2016 | 1 | |
| 3 | 2016 | 6 | |
| 4 | 2015 | 2 | |
| 5 | Expression of somatostatin type-2 and -4 receptor and correlation with histological type in breast cancer. | 2014 | 19 |
| 6 | 2014 | 47 | |
| 7 | 2014 | 18 | |
| 8 | 2013 | 15 | |
| 9 | 2013 | 9 | |
| 10 | 2013 | 21 | |
| 11 | 2012 | 22 | |
| 12 | 2012 | 3 | |
| 13 | 2012 | 4 | |
| 14 | 2011 | 12 | |
| 15 | 2011 | 23 | |
| 16 | 2011 | 5 | |
| 17 | 2010 | 16 | |
| 18 | 2010 | 26 | |
| 19 | 2009 | 6 | |
| 20 | 2006 | 5 |
About E. Chéreau
E. Chéreau is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Surgery, Cancer Research and Oncology, having authored 76 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (31 papers), Intraperitoneal and Appendiceal Malignancies (21 papers), Endometriosis Research and Treatment (17 papers), Endometrial and Cervical Cancer Treatments (16 papers), Uterine Myomas and Treatments (9 papers), Breast Cancer Treatment Studies (8 papers), Pelvic floor disorders treatments (6 papers) and Anorectal Disease Treatments and Outcomes (6 papers). The work is most often cited by research in Reproductive Medicine (754 citations), Obstetrics and Gynecology (520 citations), Surgery (586 citations), Cancer Research (151 citations) and Oncology (212 citations). E. Chéreau has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Émile Daraï, Roman Rouzier, Marcos Ballester, Frédèric Selle, Charles Coutant, Éric Lambaudie, Marc Bazot, A. Cortez, Christophe Pomel and Éric Leblanc. Their work appears in journals such as International Journal of Gynecological Cancer, American Journal of Obstetrics and Gynecology, European Journal of Surgical Oncology, Clinical Breast Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.